Positive inotropic effects of imidazoline derivatives are not mediated via imidazoline binding sites but alpha1-adrenergic receptors.

作者: K.R. Walter Raasch , Julian Chun , Andreas Dendorfer , Peter Dominiak

DOI: 10.1254/JJP.84.1

关键词:

摘要: Imidazoline-binding sites are non-adrenergic receptors and classified into I11/I2 subtypes. There is strong evidence that I1-binding sites, located in the rostro-ventrolateral medulla, involved regulation of blood pressure. However, less known about peripheral participation cardiovascular reactions. Therefore, aim this study was to investigate whether specific imidazoline derivatives influence myocardial contractility binding expressed rat heart. Agmatine, clonidine idazoxan failed alter inotropy left atria within whole concentration range tested (1 nM - 100 microM), whereas cirazoline (1- microM) moxonidine (100 increase by 20-30%. After preincubation with alpha1-adrenoceptor antagonist prazosin, stimulated antagonized, indicating more an alpha1-adrenergic site mediated mechanism. Radioligand-binding studies membranes ventricles using [3H]-clonidine specify yielded KD values 12.7 microM, confirming functional results absence rats. existence low affinity I2-binding determined [3H]-idazoxan labeling could not be excluded since a 0.5 microM calculated competition guanabenz (Ki = 0.1 58.1 129 confirmed specificity I2-binding.

参考文章(35)
Kaliszan R, Radwańska A, Comparative analysis of effects of imidazoline drugs on isolated rat heart atria. Journal of Physiology and Pharmacology. ,vol. 44, pp. 73- 87 ,(1993)
A Parini, I Coupry, R M Graham, I Uzielli, D Atlas, S M Lanier, Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor. Journal of Biological Chemistry. ,vol. 264, pp. 11874- 11878 ,(1989) , 10.1016/S0021-9258(18)80147-8
J E Waddell, R R Ruffolo, Receptor interactions of imidazolines. IX. Cirazoline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic antagonist. Journal of Pharmacology and Experimental Therapeutics. ,vol. 222, pp. 29- 36 ,(1982)
P Bousquet, J Feldman, J Schwartz, Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. Journal of Pharmacology and Experimental Therapeutics. ,vol. 230, pp. 232- 236 ,(1984)
A. Schulz, A. Hasselblatt, An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 340, pp. 321- 327 ,(1989) , 10.1007/BF00168517
Robert R. Ruffolo, Bethany S. Turowski, Popat N. Patil, Lack of cross‐desensitization between structurally dissimilar α‐adrenoceptor agonists Journal of Pharmacy and Pharmacology. ,vol. 29, pp. 378- 380 ,(2011) , 10.1111/J.2042-7158.1977.TB11344.X
J. Wagner, O. -E. Brodde, On the presence and distribution of α -adrenoceptors in the heart of various mammalian species Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 302, pp. 239- 254 ,(1978) , 10.1007/BF00508293
Martin C. Michel, Paul A. Insel, Are there multiple imidazoline binding sites Trends in Pharmacological Sciences. ,vol. 10, pp. 342- 344 ,(1989) , 10.1016/0165-6147(89)90002-3
W. RAASCH, H. MUHLE, P. DOMINIAK, Modulation of MAO Activity by Imidazoline and Guanidine Derivatives Annals of the New York Academy of Sciences. ,vol. 881, pp. 313- 331 ,(1999) , 10.1111/J.1749-6632.1999.TB09376.X
Frédérique Tesson, Isabelle Limon-Boulez, Philippe Urban, Magda Puype, Jol Vandekerckhove, Isabelle Coupry, Denis Pompon, Angelo Parini, Localization of I2-Imidazoline Binding Sites on Monoamine Oxidases Journal of Biological Chemistry. ,vol. 270, pp. 9856- 9861 ,(1995) , 10.1074/JBC.270.17.9856